Skip to main content
. Author manuscript; available in PMC: 2021 Dec 1.
Published in final edited form as: Matern Child Health J. 2020 Dec;24(12):1454–1463. doi: 10.1007/s10995-020-02995-3

Table 1:

Characteristics of the qualitative sub-sample vs. the full sample of the MCH-ART randomized controlled trial participants

Sub-Sample (n=21) Full Sample (n=471) Test Statistic (p-value)
Mean age (SD), years 27.9 (5.3) 28.6 (5.4) 0.551
Completed secondary/any tertiary education 3 (14) 114 (25) 0.311
Primiparous 2 (10) 85 (19) 0.394
Married/cohabitating 9 (43) 184 (41) 0.858
Newly diagnosed HIV+ in this pregnancy 10 (48) 258 (57) 0.380
Composite endpoint of women’s retention in ART care and VSa at 12 months postpartum 10 (50) 262 (67) 0.117
a

VS (viral suppression) is defined as VL (viral load) < 50 copies/ml based on VL testing at the MCH-ART trial measurement visit.